scholarly journals Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.

Thorax ◽  
1990 ◽  
Vol 45 (10) ◽  
pp. 759-764 ◽  
Author(s):  
N Kalsheker ◽  
K Morgan
2010 ◽  
Vol 96 (2) ◽  
pp. F114-F120 ◽  
Author(s):  
M. Laughon ◽  
C. Bose ◽  
E. N. Allred ◽  
T. M. O'Shea ◽  
R. A. Ehrenkranz ◽  
...  

BMJ ◽  
1987 ◽  
Vol 294 (6586) ◽  
pp. 1511-1514 ◽  
Author(s):  
N A Kalsheker ◽  
I J Hodgson ◽  
G L Watkins ◽  
J P White ◽  
H M Morrison ◽  
...  

2021 ◽  
Vol 8 (1) ◽  
pp. e000800
Author(s):  
Liam Knox ◽  
Rachel Gemine ◽  
Michelle Dunning ◽  
Keir Lewis

IntroductionTo enable greater availability of pulmonary rehabilitation (PR), video-conferencing technology was employed to link a community site to a standard outpatient PR service to deliver the programme closer to those with chronic respiratory disease. The service was called virtual pulmonary rehabilitation (VIPAR). To understand the experiences of those involved in this service, this study aimed to answer the question: How do the different stakeholders that interact with VIPAR experience the programme?MethodsFocus groups were conducted with people with chronic lung disease attending either the community or outpatient PR site, in addition to the staff involved in the running of the PR groups. A total of five focus groups were conducted. Reflexive thematic analysis was used to analyse the transcripts.ResultsParticipants who received VIPAR were positive regarding the programme and described the benefits of the service. Additionally, participants discussed the trade-off between convenience and relatedness. Staff described barriers to the service and solutions that could be employed to mitigate these, including greater training, organisation and understanding of risk.DiscussionUsing technology to increase the availability of PR is acceptable to the stakeholders involved, providing problems and organisational issues are resolved with training.


Sign in / Sign up

Export Citation Format

Share Document